# EDGAR Filing Document

**Accession Number:** 0001442756
**File Stem:** 0001442756-25-000004
**Filing Date:** 2025-9
**Character Count:** 30204
**Document Hash:** c24dceb486cc7606d7ca424aa14ea62f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001442756-25-000004.hdr.sgml**: 20250916

**ACCESSION NUMBER**: 0001442756-25-000004

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250916

**EFFECTIVENESS DATE**: 20250916

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PFM Health Sciences, LP
- **CENTRAL INDEX KEY:** 0001442756

**ORGANIZATION NAME:**
- **EIN:** 262000428
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-13169
- **FILM NUMBER:** 251318013

**BUSINESS ADDRESS:**
- **STREET 1:** 475 SANSOME STREET
- **STREET 2:** SUITE 1720
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94111
- **BUSINESS PHONE:** 415-281-1022

**MAIL ADDRESS:**
- **STREET 1:** 475 SANSOME STREET
- **STREET 2:** SUITE 1720
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94111

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Partner Fund Management, L.P.
- **DATE OF NAME CHANGE:** 20080812

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001442756

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** PFM Health Sciences, LP

**Address:** 475 SANSOME STREET, SAN FRANCISCO, CA 94111

**Telephone number:** 415-281-1000

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-13169

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                      | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                            | VOTE CATEGORY                |     SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| McKesson Corporation                | 58155Q103 | 07/31/2024     | Advisory vote on Executive Compensation                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |  61767           |                0 | FOR         |                          61767           | FOR                         |  |
| Immunovant, Inc.                    | 45258J102 | 08/12/2024     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES | 349915           |                0 | FOR         |                         349915           | FOR                         |  |
| Agilent Technologies, Inc.          | 00846U101 | 03/13/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |  57152           |                0 | FOR         |                          57152           | FOR                         |  |
| Intra-Cellular Therapies, Inc.      | 46116X101 | 03/27/2025     | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to ITI's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.                                                              | SECTION 14A SAY-ON-PAY VOTES | 211428           |                0 | AGAINST     |                         211428           | AGAINST                     |  |
| Humana Inc.                         | 444859102 | 04/17/2025     | Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2025 proxy statement.                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES | 120550           |                0 | FOR         |                         120550           | FOR                         |  |
| HCA Healthcare, Inc.                | 40412C101 | 04/24/2025     | Advisory vote to approve named executive officer compensation.                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |     13           |                0 | FOR         |                             13           | FOR                         |  |
| IQVIA Holdings Inc.                 | 46266C105 | 04/24/2025     | Approve an advisory (non-binding) resolution to approve IQVIA'S executive compensation (say-on-pay).                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES | 111854           |                0 | FOR         |                         111854           | FOR                         |  |
| Molina Healthcare, Inc.             | 60855R100 | 04/30/2025     | To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |  77721           |                0 | AGAINST     |                          77721           | AGAINST                     |  |
| Boston Scientific Corporation       | 101137107 | 05/01/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |  11872           |                0 | FOR         |                          11872           | FOR                         |  |
| Intuitive Surgical, Inc.            | 46120E602 | 05/01/2025     | To approve, by advisory vote, the compensation of the Company's Named Executive Officers.                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |  10835           |                0 | FOR         |                          10835           | FOR                         |  |
| Biohaven Ltd.                       | G1110E107 | 05/05/2025     | A non-binding advisory vote on the compensation of the Company's named executive officers.                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES | 363011           |                0 | FOR         |                         363011           | FOR                         |  |
| Eli Lilly and Company               | 532457108 | 05/05/2025     | Approval, on an advisory basis, of the compensation paid to the company's named executive officers.                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES | 133123           |                0 | FOR         |                         133123           | FOR                         |  |
| Danaher Corporation                 | 235851102 | 05/06/2025     | To approve on an advisory basis the Company's named executive officer compensation.                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES | 106579           |                0 | FOR         |                         106579           | FOR                         |  |
| Alnylam Pharmaceuticals, Inc.       | 02043Q107 | 05/08/2025     | To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |  66196           |                0 | FOR         |                          66196           | FOR                         |  |
| Edwards Lifesciences Corporation    | 28176E108 | 05/08/2025     | Advisory Vote to Approve Named Executive Officer Compensation                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES | 611455           |                0 | FOR         |                         611455           | FOR                         |  |
| AbbVie Inc.                         | 00287Y109 | 05/09/2025     | Say on Pay - An advisory vote on the approval of executive compensation                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES | 323029           |                0 | FOR         |                         323029           | FOR                         |  |
| Celcuity Inc.                       | 15102K100 | 05/13/2025     | To approve, by a non-binding and advisory vote, compensation of the named executive officers.                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |  82186           |                0 | FOR         |                          82186           | FOR                         |  |
| Centene Corporation                 | 15135B101 | 05/13/2025     | ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION.                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES | 229326           |                0 | FOR         |                         229326           | FOR                         |  |
| Elevance Health, Inc.               | 036752103 | 05/14/2025     | Advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |  70563           |                0 | FOR         |                          70563           | FOR                         |  |
| SpringWorks Therapeutics, Inc.      | 85205L107 | 05/14/2025     | Non-binding advisory vote on executive compensation                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |  37821           |                0 | FOR         |                          37821           | FOR                         |  |
| Syndax Pharmaceuticals, Inc.        | 87164F105 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement.                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES | 926424           |                0 | FOR         |                         926424           | FOR                         |  |
| Vertex Pharmaceuticals Incorporated | 92532F100 | 05/14/2025     | Advisory vote to approve named executive officer compensation.                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |  28717           |                0 | FOR         |                          28717           | FOR                         |  |
| Repligen Corporation                | 759916109 | 05/15/2025     | Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers.                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |  27039           |                0 | FOR         |                          27039           | FOR                         |  |
| Thermo Fisher Scientific Inc.       | 883556102 | 05/21/2025     | An advisory vote to approve named executive officer compensation.                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |  30512           |                0 | AGAINST     |                          30512           | AGAINST                     |  |
| Capricor Therapeutics, Inc.         | 14070B309 | 05/22/2025     | APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES | 126787           |                0 | FOR         |                         126787           | FOR                         |  |
| NeoGenomics, Inc.                   | 64049M209 | 05/22/2025     | Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers.                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES | 556943           |                0 | FOR         |                         556943           | FOR                         |  |
| NeoGenomics, Inc.                   | 64049M209 | 05/22/2025     | Recommend, on a non-binding advisory basis, the Frequency of Future Advisory Votes on Executive Compensation.                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES | 556943           |                0 | ONE YEAR    |                         556943           | FOR                         |  |
| Tenet Healthcare Corporation        | 88033G407 | 05/22/2025     | To approve, on an advisory basis, the Company's executive compensation.                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES | 491334           |                0 | FOR         |                         491334           | FOR                         |  |
| Waters Corporation                  | 941848103 | 05/22/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers; and                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |   7323           |                0 | FOR         |                           7323           | FOR                         |  |
| Arcellx, Inc.                       | 03940C100 | 05/28/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |  15488           |                0 | FOR         |                          15488           | FOR                         |  |
| Penumbra, Inc.                      | 70975L107 | 05/28/2025     | To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement;                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES | 166261           |                0 | FOR         |                         166261           | FOR                         |  |
| Outset Medical, Inc.                | 690145206 | 06/02/2025     | To approve, on a non-binding basis, the 2024 compensation of our named executive officers                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |  11719           |                0 | FOR         |                          11719           | FOR                         |  |
| UnitedHealth Group Incorporated     | 91324P102 | 06/02/2025     | Advisory approval of the Company's executive compensation.                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |  35904           |                0 | AGAINST     |                          35904           | AGAINST                     |  |
| Akero Therapeutics, Inc.            | 00973Y108 | 06/03/2025     | To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES | 105504           |                0 | FOR         |                         105504           | FOR                         |  |
| Keros Therapeutics, Inc.            | 492327101 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement.                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES | 104323           |                0 | FOR         |                         104323           | FOR                         |  |
| Oscar Health, Inc.                  | 687793109 | 06/04/2025     | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers.                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES | 266239           |                0 | FOR         |                         266239           | FOR                         |  |
| Xenon Pharmaceuticals Inc.          | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers;                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |  92236           |                0 | FOR         |                          92236           | FOR                         |  |
| Amylyx Pharmaceuticals, Inc.        | 03237H101 | 06/05/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executives officers.                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES | 834135           |                0 | AGAINST     |                         834135           | AGAINST                     |  |
| PMV Pharmaceuticals, Inc.           | 69353Y103 | 06/05/2025     | Approval, on a non-binding advisory basis, of the compensation of our named executive officers.                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |      3.30194e+06 |                0 | AGAINST     |                              3.30194e+06 | AGAINST                     |  |
| Verve Therapeutics, Inc.            | 92539P101 | 06/05/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers.                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES | 126071           |                0 | FOR         |                         126071           | FOR                         |  |
| Axsome Therapeutics, Inc.           | 05464T104 | 06/06/2025     | To approve, by non-binding advisory vote, the compensation of our named executive officers.                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES | 423440           |                0 | FOR         |                         423440           | FOR                         |  |
| Iovance Biotherapeutics, Inc.       | 462260100 | 06/10/2025     | To approve, by non-binding advisory vote, the compensation of our named executive officers;                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |  36767           |                0 | FOR         |                          36767           | FOR                         |  |
| uniQure N.V.                        | N90064101 | 06/11/2025     | Approval, on an advisory basis, of the compensation of the named executive officers of the Company.                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES | 177747           |                0 | FOR         |                         177747           | FOR                         |  |
| Arcutis Biotherapeutics, Inc.       | 03969K108 | 06/12/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES | 705685           |                0 | AGAINST     |                         705685           | AGAINST                     |  |
| COMPASS Pathways plc                | 20451W101 | 06/12/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended 31 December 2024                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES | 193267           |                0 | FOR         |                         193267           | FOR                         |  |
| Natera, Inc.                        | 632307104 | 06/12/2025     | To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement.                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |  57973           |                0 | FOR         |                          57973           | FOR                         |  |
| Blueprint Medicines Corporation     | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |  97088           |                0 | FOR         |                          97088           | FOR                         |  |
| BridgeBio Pharma, Inc.              | 10806X102 | 06/20/2025     | To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers.                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |      1.02371e+06 |                0 | AGAINST     |                              1.02371e+06 | AGAINST                     |  |
| Praxis Precision Medicines, Inc.    | 74006W207 | 06/26/2025     | To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2025 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion. | SECTION 14A SAY-ON-PAY VOTES | 126025           |                0 | AGAINST     |                         126025           | AGAINST                     |  |

## N-PX: Signature Block

**Reporting Person:** PFM Health Sciences, LP

**By (Signature):** Darren Mooney

**By (Printed Signature):** Darren Mooney

**By (Title):** Chief Compliance Officer and Counsel

**Date:** 09/16/2025